Skip to main content

Fordyce Marshall's Form 4 filing

Vera Therapeutics, Inc.VERA · filed Sep 27, 2024

Accession no.
0001415889-24-024033
Filed
Sep 27, 2024
Trade date
Sep 25, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 22 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.06M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fordyce MarshallCIK 0001859453Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 25, 2024Class A Common StockMOption exerciseAcquired+8,643$2.90+$25,064.7316,615Direct
Sep 25, 2024Class A Common StockSSaleDisposed−8,643$45.43F2−$392,651.49307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+4,817$2.90+$13,969.3312,789Direct
Sep 25, 2024Class A Common StockSSaleDisposed−4,817$46.62F3−$224,568.54307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+2,165$2.90+$6,278.5310,137Direct
Sep 25, 2024Class A Common StockSSaleDisposed−2,165$47.06F4−$101,884.9307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.48F5−$44,343307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79F6−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.43F5−$44,294.25307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79F7−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.48F5−$44,343307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79F7−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.44F8−$44,304307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79F7−$42,111307,972Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 25, 2024Class A Common StockMOption exerciseDisposed−15,625$0.00$0811,712Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0809,837Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0807,962Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0806,087Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0804,212Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.94 to $45.89, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.95 to $46.94, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.95 to $47.23, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.93 to $45.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 3 transactions in Table I.

F6

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.04, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.05, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 3 transactions in Table I.

F8

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.86 to $45.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)